Serum oxidative stress level correlates with clinical parameters in chronic systolic heart failure patients

Offer Amir1, Hagar Paz, Ori Rogowski

  • 1Department of Cardiology, Lady Davis Carmel Medical Center, Haifa, Israel. ruthiea@wincol.ac.il

Clinical Cardiology
|April 9, 2009
PubMed

Insights

High serum oxidative stress (OS) levels in chronic heart failure patients correlate with advanced disease. This finding highlights OS as a potential prognostic marker in heart failure management.

Area of Science:

  • Cardiology
  • Biochemistry
  • Internal Medicine

Background:

  • Oxidative stress (OS) plays a significant role in the inflammatory processes associated with heart failure (HF).
  • Understanding OS markers is crucial for managing chronic HF.

Purpose of the Study:

  • To analyze serum OS levels in patients with chronic heart failure (HF).
  • To investigate the relationship between OS levels and clinical/prognostic parameters in HF patients.

Main Methods:

  • Studied 82 chronic symptomatic HF patients with systolic left ventricular (LV) dysfunction (ejection fraction <45%).
  • Serum OS levels were quantified using a thermochemiluminescence assay.
  • OS levels were compared against clinical and prognostic patient parameters.

Main Results:

  • Elevated serum OS levels were linked to higher New York Heart Association (NYHA) class.
  • Higher OS correlated with poorer renal function, including serum urea, creatinine, and creatinine clearance.
  • Increased OS was associated with elevated levels of hs-C-reactive protein and N-terminal pro brain natriuretic peptide.

Conclusions:

  • In patients with chronic systolic HF, elevated serum OS levels are associated with more advanced disease.
  • High OS levels correlate with established markers of poor prognosis in heart failure.
Abstract

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...